Preclinical study shows transplanting insulin-producing cells and engineered blood-vessel-forming cells can reverse type 1 diabetes. The traditional method of islet transplantation has been promising but faces challenges. Using engineered human endothelial cells, researchers created a vascular network for islets to survive and function properly. When transplanted in mice, the combination of islets and R-VECs normalized blood glucose levels for over 20 weeks. The significant success in the study indicates a potential cure for type 1 diabetes in the near future. However, the translation of this technology to clinical use will require overcoming several obstacles.
https://newatlas.com/diabetes/islet-transplantation-type-1-diabetes/